Coherus Oncology, Inc.CHRSNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank77
Studio
Year-over-Year Change

Price-to-earnings ratio

Percentile
P77
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
2025-1.00-118.1%
20245.55+520.7%
2023-1.32+37.5%
2022-2.11+49.8%
2021-4.19-144.7%
20209.39-32.8%
201913.97+596.9%
2018-2.81-43.2%
2017-1.96+78.8%
2016-9.27-